TransMedics Group, Inc.
NASDAQ:TMDX
72.14 (USD) • At close February 4, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | TransMedics Group, Inc. |
Symbool | TMDX |
Munteenheid | USD |
Prijs | 72.14 |
Beurswaarde | 2,421,126,610 |
Dividendpercentage | 0% |
52-weken bereik | 55 - 177.37 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Waleed H. Hassanein M.D. |
Website | https://www.transmedics.com |
An error occurred while fetching data.
Over TransMedics Group, Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)